Home » Authors » Anette Breindl

Articles by Anette Breindl

Old RNAi Type Newly Found in the Mammalian Genome

July 25, 2008

By Anette Breindl

Refining Antibody-Drug Link Broadens Therapeutic Window

July 24, 2008

By Anette Breindl

Dimebon Improves Alzheimer's Symptoms, Vaccination Doesn't

July 18, 2008

By Anette Breindl

Same Receptor is Helpful, Harmful for HIV Infection

July 17, 2008

By Anette Breindl

Mitochondria, Innate Immunity Both Play Roles in Huntington's

July 16, 2008

By Anette Breindl

In Mice, Stem Cell Transplant Can Repair Dystrophic Muscle

July 11, 2008

By Anette Breindl

Drugs, Vaccines, Surveillance for Influenza All Get Boosts

July 10, 2008

By Anette Breindl

Putative Cancer Promoter Might be Tumor Suppressor

July 8, 2008

By Anette Breindl

Two Studies Report Complex Effects of Targeting Sirtuins

July 7, 2008

By Anette Breindl

Pharma developments: Solo or with tPA, is Gleevec a potential stroke treatment?

July 1, 2008

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...